MRTX - Mirati Therapeutics Inc
Close
58.7
-0.100 -0.170%
Share volume: 0
Last Updated: Mon 22 Jan 2024 10:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$58.80
-0.10
-0.17%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-04 | 2022-08-03 | 2022-11-08 | 2023-02-28 | 2023-05-09 | 2023-08-08 | 2023-11-06 | |
| Assets | ||||||||
| Total Assets | 1.421 B | 1.280 B | 1.303 B | 1.203 B | 1.034 B | 915.043 M | 1.130 B | |
| Current Assets | 1.343 B | 1.203 B | 1.226 B | 1.109 B | 939.350 M | 818.917 M | 1.036 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 3.020 M | 3.849 M | 8.644 M | 20.156 M | |
| Other Current Assets | 11.797 M | 10.935 M | 15.700 M | 16.072 M | 25.472 M | 25.664 M | 34.012 M | |
| Short Term Investments | 11.797 M | 10.935 M | 15.700 M | 16.072 M | 25.472 M | 25.664 M | 34.012 M | |
| Total Receivables | 4.846 M | 10.663 M | 9.092 M | 6.032 M | 7.735 M | 5.175 M | 5.478 M | |
| Current Cash | 1.326 B | 1.181 B | 1.201 B | 1.084 B | 902.294 M | 779.434 M | 976.434 M | |
| Total Non-current Assets | 78.182 M | 76.864 M | 77.300 M | 93.686 M | 94.411 M | 96.126 M | 93.628 M | |
| Property Plant Equipment | 17.177 M | 17.163 M | 17.900 M | 17.540 M | 17.185 M | 16.867 M | 16.046 M | |
| Other Assets | 20.635 M | 19.623 M | 20.438 M | 36.559 M | 37.470 M | 24.246 M | 24.199 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 14.397 M | 14.138 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 1.421 B | 1.280 B | 1.303 B | 1.203 B | 1.034 B | 915.043 M | 1.130 B | |
| Total liabilities | 172.017 M | 167.786 M | 174.030 M | 206.131 M | 171.131 M | 186.092 M | 183.243 M | |
| Total current liabilities | 123.571 M | 119.147 M | 126.986 M | 159.448 M | 124.600 M | 139.990 M | 137.379 M | |
| Accounts Payable | 27.938 M | 24.269 M | 19.452 M | 38.861 M | 22.320 M | 32.507 M | 37.961 M | |
| Other liabilities | 2.617 M | 2.816 M | 2.951 M | 3.022 M | 3.304 M | 3.380 M | 3.661 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 2.617 M | 2.816 M | 2.951 M | 3.022 M | 3.304 M | 3.380 M | 3.661 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.249 B | 1.112 B | 1.129 B | 996.516 M | 862.630 M | 728.951 M | 946.465 M | |
| Common stock | 55.469 M | 55.552 M | 56.219 M | 57.688 M | 58.032 M | 58.232 M | 64.993 M | |
| Retained earnings | -1.900 B | -2.077 B | -2.250 B | -2.453 B | -2.637 B | -2.814 B | -2.976 B |